In-depth Study of Personality Disorders in First-admission Patients with Substance Use Disorders

Overview

Journal BMC Psychiatry

Publisher Biomed Central

Specialty Psychiatry

Date 2012 Oct 31

PMID 23107025

Citations 19

Authors

Anne-Marit Langas

Ulrik Fredrik Malt

Stein Opjordsmoen

Affiliations

Soon will be listed here.

Abstract

Background: Assessment of comorbid personality disorders (PDs) in patients with substance use disorders (SUDs) is challenging due to symptom overlap, additional mental and physical disorders, and limitations of the assessment methods. Our in-depth study applied methods to overcome these difficulties.

Method: A complete catchment area sample of 61 consecutively admitted patients with SUDs, with no previous history of specialized treatment (addiction clinics, psychiatry) were studied, addressing PDs and associated clinical and demographic variables. The thorough assessments included the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV Axis II Personality Disorders.

Results: Forty-six percent of the SUD patients had at least one PD (16% antisocial [males only]; 13% borderline; and 8% paranoid, avoidant, and obsessive-compulsive, respectively). Cluster C disorders were as prevalent as Cluster B disorders. SUD patients with PDs were younger at the onset of their first SUD and at admission; used more illicit drugs; had more anxiety disorders, particularly social phobia; had more severe depressive symptoms; were more distressed; and less often attended work or school.

Conclusion: The psychiatric comorbidity and symptom load of SUD patients with PDs differed from those of SUD patients without PDs, suggesting different treatment needs, and stressing the value of the assessment of PDs in SUD patients.

Citing Articles

Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders: a prospective longitudinal cohort study.

Hetland J, Lundervold A, Erga A BMC Psychiatry. 2024; 24(1):143.

PMID: 38378466 PMC: 10880353. DOI: 10.1186/s12888-024-05600-x.

Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders - A Narrative Review.

Kock P, Meyer M, Elsner J, Dursteler K, Vogel M, Walter M Front Psychiatry. 2022; 13:827658.

PMID: 35280170 PMC: 8907594. DOI: 10.3389/fpsyt.2022.827658.

Intensive Dialectical Behavior Treatment for Individuals With Borderline Personality Disorder With and Without Substance Use Disorders.

Buono F, Larkin K, Rowe D, Perez-Rodriguez M, Sprong M, Garakani A Front Psychol. 2021; 12:629842.

PMID: 34497550 PMC: 8419465. DOI: 10.3389/fpsyg.2021.629842.

Positive Effects of Laser Acupuncture in Methamphetamine Users Undergoing Group Cognitive Behavioral Therapy: A Pilot Study.

Shiao Y, Chen Y, Yeh Y, Huang T Evid Based Complement Alternat Med. 2021; 2021:5514873.

PMID: 34122593 PMC: 8166487. DOI: 10.1155/2021/5514873.

The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability.

Carbone M, Campo G, Papaleo E, Marazziti D, Maremmani I J Clin Med. 2021; 10(8).

PMID: 33920306 PMC: 8069439. DOI: 10.3390/jcm10081616.

References

Saunders J, Aasland O, Babor T, De la Fuente J, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6):791-804. DOI: 10.1111/j.1360-0443.1993.tb02093.x. View

Driessen M, Veltrup C, Wetterling T, John U, Dilling H . Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcohol Clin Exp Res. 1998; 22(1):77-86. View

Langas A, Malt U, Opjordsmoen S . Substance use disorders and comorbid mental disorders in first-time admitted patients from a catchment area. Eur Addict Res. 2011; 18(1):16-25. DOI: 10.1159/000332234. View

Malt U, Myhrer T, BLIKRA G, HOIVIK B . Psychopathology and accidental injuries. Acta Psychiatr Scand. 1987; 76(3):261-71. DOI: 10.1111/j.1600-0447.1987.tb02894.x. View

DeRogatis L, Rickels K, Rock A . The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976; 128:280-9. DOI: 10.1192/bjp.128.3.280. View

Crawford T, Cohen P, First M, Skodol A, Johnson J, Kasen S . Comorbid Axis I and Axis II disorders in early adolescence: outcomes 20 years later. Arch Gen Psychiatry. 2008; 65(6):641-8. DOI: 10.1001/archpsyc.65.6.641. View

Pedersen G, Hagtvet K, Karterud S . Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry. 2006; 48(1):88-94. DOI: 10.1016/j.comppsych.2006.03.008. View

BERKSON J . Limitations of the application of fourfold table analysis to hospital data. Biometrics. 2010; 2(3):47-53. View

Haver B . Screening for psychiatric comorbidity among female alcoholics: the use of a questionnaire (SCL-90) among women early in their treatment programme. Alcohol Alcohol. 1998; 32(6):725-30. DOI: 10.1093/oxfordjournals.alcalc.a008322. View

10.

Landheim A, Bakken K, Vaglum P . Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics. Substance abusers treated in two counties in Norway. Eur Addict Res. 2003; 9(1):8-17. DOI: 10.1159/000067732. View

11.

Grant B, Hasin D, Stinson F, Dawson D, Chou S, Ruan W . Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions. J Psychiatr Res. 2004; 39(1):1-9. DOI: 10.1016/j.jpsychires.2004.05.004. View

12.

Hasin D, Trautman K, Miele G, Samet S, Smith M, Endicott J . Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996; 153(9):1195-201. DOI: 10.1176/ajp.153.9.1195. View

13.

Ravndal E, Vaglum P . The Millon Clinical Multiaxial Inventory II: stability over time? A seven-year follow-up study of substance abusers in treatment. Eur Addict Res. 2010; 16(3):146-51. DOI: 10.1159/000313337. View

14.

Van Horn D, Frank A . Substance-use situations and abstinence predictions in substance abusers with and without personality disorders. Am J Drug Alcohol Abuse. 1998; 24(3):395-404. DOI: 10.3109/00952999809016905. View

15.

Nace E, Davis C, Gaspari J . Axis II comorbidity in substance abusers. Am J Psychiatry. 1991; 148(1):118-20. DOI: 10.1176/ajp.148.1.118. View

16.

Verheul R, Kranzler H, Poling J, Tennen H, Ball S, Rounsaville B . Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact?. J Stud Alcohol. 2000; 61(1):101-10. DOI: 10.15288/jsa.2000.61.101. View

17.

Merikangas K, Angst J . Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiatry Clin Neurosci. 1995; 244(6):297-303. DOI: 10.1007/BF02190407. View

18.

Vassend O, Skrondal A . The problem of structural indeterminacy in multidimensional symptom report instruments. The case of SCL-90-R. Behav Res Ther. 1999; 37(7):685-701. DOI: 10.1016/s0005-7967(98)00182-x. View

19.

Haro G, Mateu C, Martinez-Raga J, Valderrama J, Castellano M, Cervera G . The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification. Eur Psychiatry. 2004; 19(4):187-92. DOI: 10.1016/j.eurpsy.2004.04.004. View

20.

Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D . Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Pers Disord. 1997; 11(3):279-84. DOI: 10.1521/pedi.1997.11.3.279. View